BIO vs CICB
BIO (BIO) versus CION Investment Corporation (CICB) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
CION Investment Corporation (CICB) common stock listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
CICB does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. CICB currently screens at market cap $0.
Not investment advice. Open the BIO and CICB stock pages for the full models.
Not investment advice.